Data Demonstrating Regimen’s Outperformance of a
Dermatologist-Recommended Control to be presented at American Academy of
Dermatology Annual Meeting
DURHAM, N.C.--(BUSINESS WIRE)--
Burt’s Bees, a leading provider of personal care products committed to
natural health and beauty solutions, today announced that the Journal
of Drugs in Dermatology has published clinical data supporting the
efficacy and tolerability of Burt’s Bees skin care products as an
adjunct to rosacea prescription therapy. Abstracts outlining the study
data will be shared at the American Academy of Dermatology Annual
Meeting on March 1-5, 2019, in Washington, D.C.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190213005152/en/
(Photo: Business Wire)
The nature-based regimen clinically and statistically improved
investigator-rated redness (erythema) by 28%; spider veins
(telangiectasia) by 26% and pimple-like skin lesions (papules/pustules)
by 34% (p<0.001) whereas a control synthetic regimen improved rosacea
symptoms by 8 to 12%. Differences between treatments were statistically
significant. Overall skin appearance measured by the investigator was
clinically and statistically improved from baseline by 32% and 12% with
the nature-based regimen and control regimens, respectively. No
clinically significant tolerability issues were reported for either
regimen at week four.
“Rosacea can be a difficult condition to manage representing an
important subset of sensitive skin. Carefully designed cleansers and
moisturizers are important to maximize treatment results,” said Zoe
Draelos, MD, President, Dermatology Consulting Services, PLLC, High
Point, NC, the study’s principal investigator. “The data suggest that
products made with nature-based ingredients can be effective when used
in conjunction with prescription therapies.”
This ten-week, single-site controlled, product-blinded study was
conducted in 80 women with Fitzpatrick skin types I-III and facial
rosacea requiring prescription medication. After baseline measurements,
subjects received six weeks of 0.75% metronidazole gel and were
randomized to receive the nature-based regimen or control regimen, twice
daily for four weeks.
“These data support the whole formula regimen of natural origin in the
management of dermatologic conditions, such as rosacea, that require
prescription medication” said Hemali Gunt, PhD, Head of Clinical and
Scientific Affairs, at Burt’s Bees. “This work further affirms our
innovations in whole formulas, designed to provide functional
ingredients to restore and protect the skin, is ideal for patients who
seek an alternative to conventional skin care products for the
management of rosacea.”
Burt’s Bees will present three abstracts featuring trial data at the
American Academy of Dermatology (AAD) Annual Meeting being held March
1-5, 2019, at the Walter E. Washington Convention Center in Washington,
D.C.
Poster#10010: Adjunctive Use of Nature-Based Skin Care Products with
Prescription Therapy According to Rosacea Severity. Hemali Gunt, PhD1,
Zoe Diana Draelos, MD2, Stanley B. Levy, MD3
1Burt's
Bees, Durham, NC; 2Dermatology Consulting Services, PLLC High
Point, NC; 3Chapel Hill Dermatology, Chapel Hill, NC,
Poster #10183: Nature-Based Skin Care Products as an Adjunct Therapy
Improve Epidermal Function in Moderate to Severe Rosacea Treated with
Metronidazole. Hemali Gunt, PhD1, Zoe Diana Draelos, MD2,
Stanley B. Levy, MD3. 1Burt's Bees, Durham, NC; 2Dermatology
Consulting Services, PLLC High Point, NC; 3Chapel Hill
Dermatology, Chapel Hill, NC
Poster #10186: Role of Nature-Based Skin Care Products as Adjunct
Therapy in Subjects with Moderate to Severe Rosacea. Zoe Diana
Draelos, MD1, Hemali Gunt, PhD2, Stanley B. Levy,
MD3. 1Dermatology Consulting Services, PLLC High
Point, NC; 2Burt's Bees, Durham, NC; 3Chapel Hill
Dermatology, Chapel Hill, NC.
About the study | This study was single site, controlled,
product-blinded and performed on 80 female subjects between 25-70 years
of age possessing Fitzpatrick skin type’s I-III with facial rosacea
requiring prescription medication. Subjects who met inclusion/exclusion
criteria entered a 6-week open-label run in period in which they were
treated with topical 0.75% metronidazole gel twice daily. No other
topical or oral rosacea medications were allowed. Following baseline
assessments of the investigator global rosacea assessment, investigator
rated efficacy, evaporimetry for transepidermal water loss and
corneometry for shin hydration; subjects were then randomized to receive
4 weeks of either the nature based sensitive skin regimen or the control
regimen. The Burt’s Bees Skin Care Regimen included Burt’s Bees
Sensitive Facial Cleanser (used twice daily), Burt’s Bees Sensitive
Daily Moisturizing Cream (applied in the morning) and Burt’s Bees
Sensitive Night Cream (used in the evening). The Control Skin Care
Regimen included Cetaphil Gentle Skin Cleanser (used twice daily) and
Cetaphil Moisturizing Lotion (used twice daily). Evaluations repeated at
2 and 4 weeks. Read the full-text citation: Draelos, ZD, Gunt, H, and
Levy, SB.Natural skin care products as adjunctive to
prescription therapy in moderate to severe rosacea.J Drugs
Dermatol. 2019; 18(2):141-146. : LINK
About Burt’s Bees | Burt's Bees® has been offering
distinctive earth-friendly, natural health and beauty care products for
over 30 years. From a beekeeper's backyard in Maine to the leading edge
of natural, Burt's Bees knows natural solutions for beauty from the
inside out and operates with The Greater Good™ top of mind. Formulated
without parabens, phthalates, petrolatum or SLS. No animal testing. To
find out more, visit www.burtsbees.com.
NYSE: CLX CLX-B.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190213005152/en/
RXMD for Burt’s Bees
Maria Hasapoglou, 212-537-9495
Burtsbees@rxmedyn.com
Source: Burt’s Bees